Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.11B
Enterprise Value2.25B
P/E Ratio184.04
PEG Ratio-2.78
Price/Sales Ratio10.47
Price/Book Ratio27.14
Enterprise/Revenue11.1
Enterprise/EBITDA69.9

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.15

Income Statement

Revenue210.66M
Revenue/Share1.66
Gross Profit82.33M
EBITDA51.08M
Net Income17.62M
Diluted EPS0.14

Balance Sheet

Total Cash36.39M
Total Cash/Share0.3
Total Debt164.94M
Total Debt/Equity2.11
Current Ratio0.83
Book Value Per Share0.83

Price History

52-Week Change-8.27
52-Week High24.25
52-Week Low15.7
Moving Average 50 Days20.93
Moving Average 200 Days20.09

Statistics

Average Volume3.18M
Shares Outstanding121.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.53
Last Split Factor10177:10000
Last Split DateMay 04, 2009
AD